Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration

Overview of attention for article published in Cell, September 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 18 patents

Readers on

mendeley: 132 Mendeley

So far, Altmetric has seen 18 patents that reference this research output.

Compositions and methods for treating muscular dystrophy and other disorders

Grant US-12478634-B2

United States of America

25 Nov 2025

METHODS FOR TREATING MUSCLE-RELATED DISORDERS BY MODULATING PROLYL HYDROXYLASE 3

Application WO-2025049599-A1

World Intellectual Property Organisation (WIPO)

06 Mar 2025

GENE THERAPY FOR TREATING LIMB GIRDLE MUSCULAR DYSTROPHY R9 AND CONGENITAL MUSCULAR…

Application WO-2024220592-A2

World Intellectual Property Organisation (WIPO)

24 Oct 2024

Compositions and methods for treating muscular dystrophy and other disorders

Grant US-11931371-B2

United States of America

19 Mar 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 14 additional patents.